Pharmacological management of pulmonary embolism.

about

Use of direct oral anticoagulants for chronic thromboembolic pulmonary hypertension.

P2860

Q55294784-B73DE4A6-3492-4DAA-8F87-48D793469247

P2860

Pharmacological management of pulmonary embolism.

Item

http://www.wikidata.org/entity/Q39029202

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Pharmacological management of pulmonary embolism.

@en

Pharmacological management of pulmonary embolism.

@nl

type

Item

label

Pharmacological management of pulmonary embolism.

@en

Pharmacological management of pulmonary embolism.

@nl

prefLabel

Pharmacological management of pulmonary embolism.

@en

Pharmacological management of pulmonary embolism.

@nl

P1476

Pharmacological management of pulmonary embolism.

@en

P2093

Bobby Gouin

http://www.w3.org/2001/XMLSchema#string

Helia Robert-Ebadi

http://www.w3.org/2001/XMLSchema#string

Marc Blondon

http://www.w3.org/2001/XMLSchema#string

Marc Righini

http://www.w3.org/2001/XMLSchema#string

P2860

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Idarucizumab for Dabigatran Reversal

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Oral rivaroxaban for symptomatic venous thromboembolism

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.

P304

79-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2016.1268122

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27917690

http://www.w3.org/2001/XMLSchema#string

Pharmacological management of pulmonary embolism.

about

P2860

P2860

Pharmacological management of pulmonary embolism.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698